Logotype for Indigo Paints Limited

Indigo Paints (INDIGOPNTS) Q3 24/25 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Indigo Paints Limited

Q3 24/25 earnings summary

18 Dec, 2025

Executive summary

  • Q3 FY25 revenue declined 4% year-over-year due to persistent demand slowdown, while nine-month revenue grew 3.5% year-over-year; gross margins remained strong at 47.2% in Q3 FY25, though slightly lower than last year.

  • EBITDA and PAT declined year-over-year, with Q3 FY25 consolidated EBITDA margin at 16.7% and PAT margin at 10.4%; nine-month EBITDA margin at 15.3% and PAT margin at 8.8%.

  • Emulsion segment showed resilience with positive value and volume growth, driven by premium products, while other segments saw declines.

  • Active dealer count reached 18,600 and printing machine population 10,800 as of December 2024.

  • Key management changes included the resignation of the Company Secretary and Compliance Officer, effective February 18, 2025, and the appointment of a new Company Secretary effective April 16, 2025.

Financial highlights

  • Standalone Q3 FY25 revenue: ₹327.5 Cr (-4.0% YoY); consolidated Q3 FY25 revenue: ₹342.6 Cr (-3.2% YoY); nine-month consolidated revenue: ₹953.1 Cr (+3.5% YoY).

  • Standalone Q3 FY25 EBITDA: ₹57.3 Cr (-5.9% YoY); consolidated Q3 FY25 EBITDA: ₹57.2 Cr (-8.1% YoY); nine-month consolidated EBITDA: ₹146.1 Cr (-4.8% YoY).

  • Standalone Q3 FY25 PAT: ₹36.5 Cr (-3.3% YoY); consolidated Q3 FY25 PAT: ₹35.8 Cr (-4.5% YoY); nine-month consolidated PAT: ₹84.8 Cr (-10.1% YoY).

  • Treasury investments stood at INR 196 crore as of December 31, 2024, after funding all CapEx internally.

  • Standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, were approved with an unmodified review report.

Outlook and guidance

  • January 2025 showed significant improvement in year-over-year growth, with expectations of gradual recovery and potential high single-digit or low double-digit growth in Q4 FY25.

  • Management anticipates demand recovery supported by favorable monsoons, government stimulus, and lower interest rates.

  • Expects margin expansion with higher growth in premium products and improved product mix.

  • Sequential improvement in EBITDA margin and Apple Chemie profitability anticipated in Q4 FY25.

  • No plans to introduce latex-based paints, as current market feedback shows limited traction.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more